ALBANY, N.Y., March 26, 2014 /PRNewswire/ -- Albany Molecular
Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive
Officer at AMRI, will present at the Thirteenth Annual Needham
Healthcare Conference on Wednesday, April 9,
2014 at 10:00 a.m. ET.
A webcast of the presentation can be accessed at the Investor
Relations' section of www.amriglobal.com, or at the following URL:
http://wsw.com/webcast/needham65/AMRI/
The webcast will be archived for 90 days following the live
presentation.
About AMRI
Albany Molecular Research, Inc. (AMRI) is a global contract
research and manufacturing organization offering customers fully
integrated drug discovery, development and manufacturing services.
For over 22 years, AMRI has demonstrated its adaptability as the
pharmaceutical and biotechnology industries have undergone
tremendous change in response to multiple challenges. This
experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with
SMARTSOURCING™, a full range of value-added opportunities providing
customers informed decision-making, enhanced efficiency and more
successful outcomes at all stages of the pipeline. AMRI has also
successfully partnered R&D programs and is actively seeking to
out-license its remaining programs for further development. For
more information about AMRI, please visit our website at
www.amriglobal.com or follow us on Twitter (@amriglobal).
SOURCE AMRI